UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 334

Sortiert nach

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

Cell, 2020-12, Vol.183 (6), p.1634-1649.e17

2020

Volltextzugriff (PDF)

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2039-2045

2012

Volltextzugriff (PDF)

Uterine carcinosarcoma: A review of the literature

Gynecologic oncology, 2015-06, Vol.137 (3), p.581-588

2015

Volltextzugriff (PDF)

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

Gynecologic oncology, 2015-10, Vol.139 (1), p.10-16

2015

Volltextzugriff (PDF)

Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis

Gynecologic oncology, 2021-08, Vol.162 (2), p.506-516

2021

Volltextzugriff (PDF)

The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life

International journal of gynecological cancer, 2021-02, Vol.31 (2), p.238-244

2021

Volltextzugriff (PDF)

Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer

American journal of obstetrics and gynecology, 2020-11, Vol.223 (5), p.725.e1-725.e9

2020

Volltextzugriff (PDF)

Yes, it's true: Benign hysterectomy trends for gynecologic oncologists in the United States from 2015 to 2021

Gynecologic oncology, 2024-10, Vol.189, p.125-128

2024

Volltextzugriff (PDF)

Letters of recommendation for gynecologic oncology fellowship differ by gender and race

Gynecologic oncology, 2023-10, Vol.177, p.9-13

2023

Volltextzugriff (PDF)

Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists

Gynecologic oncology, 2024-05, Vol.184, p.43-50

2024

Volltextzugriff (PDF)

Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors

Gynecologic oncology, 2024-07, Vol.186, p.176-181

2024

Volltextzugriff (PDF)

Houston, We Have a Problem: How Changes in Gynecologic Oncology Represent Broader Concerns for the Future of Obstetrics and Gynecology

Obstetrics and gynecology (New York. 1953), 2023-07, Vol.142 (1), p.1

2023

Volltextzugriff (PDF)

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Gynecologic oncology, 2021-02, Vol.160 (2), p.492-498

2021

Volltextzugriff (PDF)

Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy

Gynecologic oncology, 2023-07, Vol.174, p.273-277

2023

Volltextzugriff (PDF)

Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report

Gynecologic oncology, 2023-04, Vol.171, p.76-82

2023

Volltextzugriff (PDF)

Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects

Gynecologic oncology, 2024-08, Vol.187, p.151-162

2024

Volltextzugriff (PDF)

Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic

Gynecologic oncology, 2024-04, Vol.183, p.47-52

2024

Volltextzugriff (PDF)

Coronavirus concerns: What do women with gynecologic cancer need to know during the COVID-19 crisis?

Gynecologic oncology, 2020-07, Vol.158 (1), p.32-33

2020

Volltextzugriff (PDF)

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

Advances in therapy, 2022-06, Vol.39 (6), p.2544-2561

2022

Volltextzugriff (PDF)

Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system

Gynecologic oncology reports, 2024-06, Vol.53, p.101372-101372, Article 101372

2024

Volltextzugriff (PDF)

A first radiotherapy application of functional bulboclitoris anatomy, a novel female sexual organ-at-risk, and organ-sparing feasibility study

British journal of radiology, 2021-08, Vol.94 (1124), p.20201139

2021

Volltextzugriff (PDF)

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic

Gynecologic oncology, 2022-02, Vol.164 (2), p.304-310

2022

Volltextzugriff (PDF)

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1389-1397

2020

Volltextzugriff (PDF)

“It was a no-brainer”: A qualitative study of factors driving previvors’ decision-making when considering risk-reducing salpingectomy with delayed oophorectomy

Gynecologic oncology reports, 2022-04, Vol.40, p.100948-100948, Article 100948

2022

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(307)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Uterine carcinosarcoma: A review of the literature

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis

The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life

Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer

Yes, it's true: Benign hysterectomy trends for gynecologic oncologists in the United States from 2015 to 2021

Letters of recommendation for gynecologic oncology fellowship differ by gender and race

Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists

Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors

Houston, We Have a Problem: How Changes in Gynecologic Oncology Represent Broader Concerns for the Future of Obstetrics and Gynecology

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy

Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report

Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects

Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic

Coronavirus concerns: What do women with gynecologic cancer need to know during the COVID-19 crisis?

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system

A first radiotherapy application of functional bulboclitoris anatomy, a novel female sexual organ-at-risk, and organ-sparing feasibility study

What happens in the long term: Uptake of cancer surveillance and prevention strategies among at‐risk relatives with pathogenic variants detected via cascade testing

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling

“It was a no-brainer”: A qualitative study of factors driving previvors’ decision-making when considering risk-reducing salpingectomy with delayed oophorectomy

Suchergebnisse filtern